Tag Archives: Alzheimer’s

Hallmarks of Alzheimer’s Are Stimulated by This Substance

Editor’s Note: This article is a reprint. It was originally published March 10, 2019. Boyd Haley, Ph.D., is a chemist specializing in the development of chemicals to chelate toxic metals, both from the environment and the human body. I had the opportunity to interview Haley (above) at the 2018 Academy of Comprehensive Integrative Medicine (ACIM)… Read More »

FDA Gives Accelerated Approval for Risky Alzheimer’s Pill

The U.S. Food and Drug Administration granted accelerated approval for the Alzheimer’s disease drug lecanemab (Leqembi). The drug, a monoclonal antibody, binds to amyloid beta in the brain. An 18-month study published in the New England Journal of Medicine1 found Leqembi reduced markers of amyloid in early Alzheimer’s disease and led to “moderately less decline”… Read More »